Why is Welcure Drugs falling/rising?

As of 19-Nov, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 0.54, with a change of -0.02, representing a decrease of 3.57%. The stock has been underperforming significantly, having lost 15.63% over the last four days and showing a substantial decline of 27.03% over the past month. Additionally, it is trading below all key moving averages, indicating a bearish trend. The delivery volume has also decreased sharply, falling by 65.33% compared to the five-day average, which suggests a lack of investor interest. Unfortunately, there are no positive or negative factors provided to further explain the stock's recent movement.
In the broader market context, Welcure Drugs has underperformed relative to the Sensex, which has gained 0.85% over the past week while the stock has dropped 11.48%. Year-to-date, the stock has fallen by 48.59%, contrasting sharply with the Sensex's increase of 9.02%. This stark difference highlights the challenges faced by Welcure Drugs in attracting investor confidence compared to the overall market performance.